Advent Pharma Ltd. Sustainability Profile
Advent Pharma Ltd., a prominent player in the pharmaceutical industry, is headquartered in Bangladesh (BD) and has established a significant presence across various operational regions. Founded in 2004, the company has achieved notable milestones, positioning itself as a trusted provider of high-quality medicines and healthcare solutions. Specialising in the development and manufacturing of generic pharmaceuticals, Advent Pharma offers a diverse portfolio that includes formulations for chronic and acute conditions. Their commitment to innovation and quality sets them apart in a competitive market, ensuring that they meet the evolving needs of healthcare professionals and patients alike. With a strong focus on research and development, Advent Pharma Ltd. has garnered recognition for its contributions to the industry, solidifying its market position as a reliable source of effective and affordable medications.
DitchCarbon Score
How does Advent Pharma Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Advent Pharma Ltd.'s score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Advent Pharma Ltd.'s reported carbon emissions
Advent Pharma Ltd., headquartered in Bangladesh (BD), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Advent Pharma Ltd. may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and climate action. While Advent Pharma Ltd. has not yet disclosed its emissions or commitments, it is essential for organisations in this sector to consider setting measurable targets to align with global climate goals and enhance their environmental responsibility.
How Carbon Intensive is Advent Pharma Ltd.'s Industry?
How Carbon Intensive is Advent Pharma Ltd.'s Location?
Advent Pharma Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Advent Pharma Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.